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This Mini-Review presents recent research into evidence for psychological treatments for
people with severe and enduring anorexia nervosa (SEAN). Two psychological therapies,
specialist supportive clinical management (SSCM), and cognitive behavior therapy for
anorexia nervosa (CBT-AN) have limited (one randomized controlled study) evidence of
efficacy. Both have had adaptations for SEAN, notably with revision of the primary
treatment goal of improved quality of life and full weight recovery a secondary goal. A
major issue with existing studies is poor definition of SEAN, and the large deficit in
research that has used an agreed definition of SEAN. In particular, it may be problematic
to extrapolate from studies of people with either severe and/or enduring but not intractable
or “resistant” illness. People with longstanding AN who have not received evidence based
care should be offered this with an expectation of recovery. Similarly, people with SEAN
may be offered care with judicious mitigation of expectations. In the future, trials should
include people with SEAN clearly defined. Trials with a subsample of participants likely to
have SEAN, if identified at randomisation, are an opportunity for secondary analyses of
such participants. This would widen the evidence base for psychological treatments
providing hope for people with this devastating illness. Finally, there is an urgent need not
only to strengthen our existing knowledge with studies of sufficient power, but also,
fundamentally, to derive novel conceptualizations of what “treatment” involves.
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Anorexia nervosa (AN) is a serious mental disorder affecting 1.4% of women and 0.2% of men
worldwide in their lifetime (1). A significant number of people with AN remain ill for many years,
with treatment becoming increasingly challenging and expensive as the disease progresses and
recovery is less likely (2, 3). These individuals have the highest mortality rate of all mental disorders
and suffer personal and fiscal impoverishment (4, 5). It is essential to stress that both treatment and
recovery may occur decades after onset and that illness should not be regarded as intractableg March 2020 | Volume 11 | Article 2061
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to approach the assessment of people with AN holistically.
In this paper the proposed criteria for severe and enduring
AN (SEAN) [(7), p. 2] will be used. These are the presence of:
“(1) a persistent state of dietary restriction, underweight, and
overvaluation of weight/shape with functional impairment; 2)
duration of > 3 years of anorexia nervosa; and, (3) exposure to at
least two evidence based treatments appropriately delivered
together with a diagnostic assessment and formulation that
incorporates an assessment of the person's eating disorder
health literacy and stage of change.” One major problem with
these criteria is that the mean duration of illness in adults at the
time of first presentation is frequently much more than 3 years,
and some definitions of SEAN include an illness duration of > 7
years. Notwithstanding this limitation, these criteria capture the
concept of SEAN as used in this paper.
Approaches to the care of people with SEAN have to date
been based on consensus judgments and “clinical wisdom” with
few clinical trials (8). There are mixed views on goals of
treatment, with some suggesting these should be modified to
aim for improved quality of life as a primary outcome (9, 10)
whilst others promote a view that the aim of full weight recovery
should remain the primary goal no matter the length or severity
of illness (11). When undertaking treatment in those with SEAN,
a unique challenge is posed for clinicians as patients are very
unwell, often appear poorly motivated, feel very alone and
unsupported, and experience an overwhelming sense of
hopelessness (12). These people experience unremitting and
insistent ruminations on food, shape, and weight and
treatments aiming for “complete cure” may have little impact.
Singularly offering treatments focused on traditional goals
(primarily of weight restoration and amelioration of disordered
eating symptoms) and physical and psychological recovery may
be inappropriate for such individuals, and this mismatch in
clinician and patient goals could further contribute to low
retention rates (8).
A systematic review in 2012 (13) of randomized controlled trials
(RCTs) highlighted the paucity of evidence based treatment for
SEAN. This review included participants with AN and an illness
duration of 3 or more years. It identified 11 trials, of which four had
amajority of such participants. Findings were very limited and there
was an absence of evidence for any psychological treatment to be
first line in treatment, in contrast to medication which has generally
been found to be non-efficacious or non-feasible as a first-line
treatment. It was concluded that there may be an advantage for
specialist vs non-specialist care and cognitive behavior therapy for
AN (CBT-AN) may reduce relapse when used following weight
restoration. All studies of any treatments required replication and
there was no RCT specifically for treatment of people with SEAN.
The 2012 review (13) did, however, identify several psychological
therapies that appeared to address issues relevant to people with
SEAN, namely comorbidities of mood intolerance and depression,
functional impairments, personality vulnerabilities and interpersonal
deficits, low motivation to change, and/or modification of treatmentFrontiers in Psychiatry | www.frontiersin.org 2goals towards quality of life. These therapies were: Specialist
Supportive Clinical Management [SSCM (10)], CBT-AN (11), the
Community Outreach Partnership Program [COPP (14)], Maudsley
Model of Anorexia Nervosa Treatment for Adults [MANTRA (15)],
and that described by Strober (12). A transdiagnostic CBT enhanced–
broad [CBT–Eb (16)] therapy was also included as it widened the
components of treatment to add modules addressing comorbidities,
interpersonal therapy, clinical perfectionism, and low self-esteem.
There are shifts towards more collaborative treatment and aims to
improve quality of life, however, all these therapies emphasize the
importance of ensuringmedical safety and encourage, if not mandate,
weight gain. Finally, only SSCM, CBT-AN, MANTRA, and CBT-E
have been tested in a RCT against a control (active or inactive)
treatment for people with AN.
The lack of evidence based treatments for SEAN may have
negative effects and result in loss of hope for both patients and
clinicians, leading them to seek alternative and less conventional
treatment goals and therapies. Wonderlich et al. (8) stated that
these attempts to accommodate treatment for SEAN patients
may result in “relatively unfocused, intermittent, supportive
interventions, where goals become unclear and monitoring of
clinical status becomes impressionistic and imprecise.” There is
little to guide clinicians in challenging areas such as when to use
involuntary treatment and the ethics of, and role of, non-specific
medical palliation in these patients (17, 18). Strober (2004)
reasoned that the objective of care in patients with SEAN may
be to support the patient and make up for the effects of the
disease—a palliative, holding management that offers support
and comfort to partially alleviate the effects of the disease (12).
Given the challenging nature of SEAN treatment, researchers
and clinicians are now exploring novel biological treatments based
on a neuroscientific understanding of the disorder (19). These
include brain-directed treatments such as neuromodulation with
non-invasive (20) and deep brain stimulation (21, 22). Novel
medications such as dronabinol, a synthetic cannabinoid (23)
have also begun to be investigated. However, even if such
experimental adjunctive biological approaches are found to
improve patient outcomes, they should always be considered
adjunctive strategies, used in combination with evidence based
psychological treatments, and in accordance with sound ethical
guidelines (24).
Since the 2012 systematic review (13) there have been further
RCTs of treatment for people with SEAN and a Cochrane review
of psychological therapies is in progress (21). This Mini-Review
aims to (1) provide an overview of psychological treatment trials
and other studies identified since the 2012 review in the course of
a recent literature search (25), and (2) discuss treatment gaps and
future research directions. Therapy trials are considered that
were either a primary RCT for people with SEAN or included a
substantive proportion of people with long-standing illness (e.g.,
median illness of more than 3 years) who may represent a
subgroup of people with SEAN. In this Mini-Review inpatient
as well as outpatient trials are considered. An overview included
trials is found on Table 1.March 2020 | Volume 11 | Article 206
Zhu et al. Psychological Treatments for SEANPSYCHOLOGICAL TREATMENT TRIALS
Primary Trial of SEAN
To our knowledge there has been only one RCT evaluating
specific psychological treatment for people with SEAN (9, 10).
This trial compared two evidence based treatments for AN that
were modified for people with SEAN, namely SSCM (34) and
CBT-AN (35). In this study SEAN was defined as having a
minimum illness duration of 7 years. In both treatment
conditions there was a broadening of treatment goals to focus
on quality of life and a lessening of the priority to achieve weight
gain. Both therapies also highlighted the importance of
collaborative goal setting to address patient preferences, with
the aim to improve engagement, motivation, and retention rates.
This trial did achieve very high rates of treatment completion—
with 76% completing more than 30 weeks of therapy. There were
significant improvements in eating disorder symptoms, health
related quality of life and weight for all participants, which were
sustained to 1-year follow-up. Whilst there were few significant
differences between groups in primary or secondary outcomes,
those with more severe symptoms, depression, an older age, and
who were purging, benefited more from the modified CBT-AN
(36). CBT-AN was also superior to SSCM in reducing core eating
disorder symptoms at follow-up. For all participants improved
eating disorder symptoms and increased weight also predicted a
significantly better health related quality of life (10).
Trials That Included Participants With
Long-Standing Illness
Dalle-Grave CBT-E Trial
In 2013, Dalle Grave et al. (26) reported the immediate and
longer-term effects of CBT-E in focused and broad forms in 80
young adults with severe AN and a median illness duration of 5
years. In this RCT both treatments significantly improved
weight, eating disorder and general psychopathology in
participants, and whilst deterioration did occur after discharge,
it was not marked and only for a short duration. Furthermore, as
there were no statistically significant differences between the two
therapies, it was suggested that there appears to be no benefit of
using the more complex CBT-Eb treatment. Thus, whilst Hay
et al. (13) postulated that the broader form of CBT-E would offer
benefits over the focused form for people with longer illness
duration, this was not supported in this study. This may have
been because SEAN encompasses the concept of previous
treatment intractability as described above, and not merely
longstanding symptoms. This trial was also conducted in an
inpatient treatment setting where there was additional nutritional
support from dietitians. Interestingly no psychotropic drugs
were prescribed.
Maudsley Model of Anorexia Nervosa Treatment for
Adults (MANTRA) Trials
MANTRA has not been evaluated in a SEAN group. However, it
employs a motivational interviewing style, has as a model
individualized care, and optional modules can include the
development of a “non-anorexic” identity that was conceivedFrontiers in Psychiatry | www.frontiersin.org 3for patients with enduring illness. (27, 37). MANTRA has been
evaluated in two RCTs against SSCM in participants with lengthy
(mean 8 and 7 years) illness durations. In these RCTs both
therapies resulted in statistically significant improvements in
BMI, reductions in ED symptomatology, other psychopathology,
and clinical impairment over time. Notably, at 2-year follow-up
(37) MANTRA was assessed to be statistically significantly more
acceptable and credible by patients at 12 months, with higher
treatment completion rates. This is a relevant finding as patients
with SEAN have notoriously high attrition rates.
The Anorexia Nervosa Treatment of OutPatients
(ANTOP) Trial
A treatment more recently evaluated in RCTs in AN is focal
psychodynamic therapy (FPT). FPT is a three-phase treatment
that focuses on interpersonal relationships (28). In FPT initially a
therapeutic relationship is developed and self-esteem, pro-anoretic
behavior, and ego-syntonic beliefs are addressed. Treatment then
shifts to target associations between AN behaviors and interpersonal
relationships. Finally preparations are made for independent
recovery. The Anorexia Nervosa Treatment of OutPatients
[ANTOP (28)] study was a large (n = 242) multi center RCT
aimed to assess the efficacy of FPT and CBT-E against an optimized
treatment as usual (TAU). Ninety-four (39%) of participants had
AN for longer than 6 years. At the end of treatment (10 months
after start of treatment) all groups had gained weight with no
difference in weight gain between groups. All participants also
exhibited decreased general and eating disorder-specific
psychopathology. At 12-month follow-up, people allocated to FPT
had significantly higher full recovery rates compared with those
assigned to optimized TAU as usual, but there was no significant
difference in recovery rates between the CBT-E and FPT groups.
Moreover, CBT-E was found to be more effective in terms of speed
of weight gain and improvements in eating disorder
psychopathology and appeared to offer an advantage for those
with lower baseline weight.
Cognitive Remediation Therapy (CRT)
CRT was initially a form of management for patients with brain
lesions and schizophrenia. A modified form of CRT was
developed by Tchanturia et al. (38) for AN. It is a focused
treatment that targets a patient's cognitive inflexibility, thought
to be a factor in both the development and maintenance of the
illness. With inefficient cognitive flexibility, patients may exhibit
obsessive preoccupations related to body shape, weight, and food
as well as ritualistic behaviors. Through improvement of basic
neurocognitive functions, it is thought that perseverative
behaviors in anorexia nervosa may be addressed. Instead of
looking at what a patient thinks, how they think is examined
and it is thought that the proliferation of neural connections due
to CRT training results in more flexible thought and behaviors.
In an RCT, Dingemans et al. (29) investigated the effectiveness of
10-session CRT for 82 patients with severe or enduring eating
disorders by comparing intensive TAU to CRT plus TAU. Forty-
six percent of participants had >7 years of illness duration and
93% had a history of AN. Patients who underwent CRT in
addition to TAU improved significantly more in eating disorder-March 2020 | Volume 11 | Article 206
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psychopathology at follow-up when compared to TAU only
patients. Whilst Dingemans et al. (29) confirmed the findings
of previous uncontrolled case studies using CRT, it should be
noted that this trial was not in SEAN patients only, but rather a
mix of severe or enduring eating disorder patients. No studies
have been conducted with CRT in exclusively SEAN patients.
Brockmeyer et al. (30) also have investigated CRT in a small
pilot RCT of people with AN with mean illness duration > 6
years. They only examined outcomes in the 25 participants who
completed treatment and only reported on neurocognitive
findings. CRT was compared with a non-specific neuro
cognitive therapy that focused solely on attention, memory,
and deductive reasoning, and not flexibility. The primary
outcome was cognitive set-switching which was superior at end
of treatment in the CRT group.
Exposure and Response Prevention for
Anorexia Nervosa
Exposure and Response Prevention for AN (AN-EXRP) is a
manualized method of treatment that was formed to focus on
eating-related anxieties and alter dysfunctional eating behaviors
through encouraging the confrontation of fears. (31) AN-EXRP
modifies these strategies to target eating-related symptoms with
particular focus on exposure and ritual prevention. Patients are
progressed through a hierarchy of provocative eating situations
and attention is brought to stopping ritualistic behaviors and the
eventual dissipation of anxiety. Steinglass et al. (31) performedFrontiers in Psychiatry | www.frontiersin.org 5an RCT to evaluate AN-EXRP as an adjunctive strategy to improve
eating behavior during weight restoration and compared it with
CRT. This study was conducted with participants with AN and a
mean illness duration of 10 years. Participants randomized to AN-
EXRP had significantly better change in food intake in a test meal
than CRT (i.e. average intake increased by approximately 50 kcal
compared to a decrease of 77 kcal in the CRT group). Whilst these
findings could suggest that AN-EXRP may support continuation of
healthy behaviors, a key limitation of the study was that the
intervention was delivered adjunct to an intensive treatment and
so results cannot be attributed to AN-EXRP alone.
Community Outreach Partnership Program (COPP)
COPP was developed as an outpatient, multidisciplinary form of
treatment that differed to traditional approaches in that its goals
were improving quality of life instead of targeting the eating
disorder. (14) Patient autonomy and self-esteem are improved
through skill building and problem solving, and support systems
that favor community supports instead of traditional health care
providers and hospitals, are developed. A harm reduction model
is utilized, where there is collaboration between patient and
therapist in an attempt to minimize consequences that may arise
from disordered eating behaviors. The program employs
strategies from psychosocial rehabilitation and motivational
interviewing. Preliminary outcome results have been reported
from a small uncontrolled study by Williams et al. (14) in
patients with eating disorders (mean duration of eating
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evaluation in RCTs as an alternative model of care for
individuals with long-standing eating disorders.
Regulating Emotions and Changing Habits (REaCH)
REaCH is a behavioral treatment focused on prompts for
disordered eating behaviors and was based upon treatments
that have seen success in complex behaviors such as habit
reversal therapy for Tourette's syndrome. (32) It has been
postulated that patients with AN develop restrictive eating
behaviors that eventually grow into entrenched reflex
responses to certain cues and thus are considered habits.
REaCH is a manualized treatment with four main components
including cue-awareness, the development of new routines, the
repression of detrimental habits, and emotional regulation. In a
proof-of-concept RCT by Steinglass et al. (32) 22 hospitalized
patients with AN were randomly assigned to either Supportive
Psychotherapy (SPT) or REaCH (mean duration of illness was
12.7 and 15.5 years respectively). Study findings demonstrated
that REaCH more effectively altered habit strength of
maladaptive routines compared to SPT and was associated
with clinically meaningful improvements in eating disorder
symptoms and energy intake.
Motivational Interviewing (MI)
Weiss et al. (33) tested a four-session weekly MI therapy prior to
an intensive hospital program in 39 eating disorder participants
(65% with AN) with mean illness duration >10 years. The
primary outcome was program completion which was
significantly higher in the MI group than a control (wait list)
arm. However, there were no differences in measures of
motivation and thus the mechanism of the effect was unclear.DISCUSSION
Whilst there has been some progress in psychological treatment
research in AN there remains a grave paucity of trials, and a total
of one only (9) for those with severe enduring illness. The
situation is further confused by lack of staging patient's illness.
As many trials include participants who may have SEAN there is
an opportunity to stratify by presence or absence of SEAN and
conduct post-hoc sub-group analyses in large trials. However,
this rests on an agreed definition of SEAN and it is likely the
third suggested criterion of treatment intractability would not be
known and/or would have been met, which limits this as a meansFrontiers in Psychiatry | www.frontiersin.org 6of advancing knowledge. Indeed, it was not a criterion in the
single trial of SEAN (9). There is an urgent need not only to
strengthen our existing knowledge through larger RCTs of
sufficient power, but also, fundamentally, to derive novel
conceptualizations of what “treatment” involves, beyond
traditional directive and paternalistic models of the past which
all too often render patients institutionalized, traumatized, and/
or disempowered.
There needs to be an increased effort in determining how this
particular population of patients is best empowered to recover.
This should be mindful of respecting patients' preferences which
are too often neglected in this area (39). Unanswered research
questions include: what are the moderators of specific therapies
so we can better manage patients with different presentations;
how can we avoid providing ineffective treatment, and thus
periods of undernutrition, to patients who are unlikely to
respond to a certain treatment; what is the role of new
technologies such as transcranial direct current stimulation in
delivering psychotherapy and support to these chronic patients;
and, might there be a more suitable and accurate way to
categorize anorexia nervosa such as the hybrid model of
categories and dimensions suggested by Wildes (40)?
In conclusion, advances have been made in bringing to public
awareness the distinction between acute presentations of AN and
that of the severe and less tractable kind. There are several
psychological therapies with an emerging evidence base that can
be further tested and adapted for SEAN treatment. Research to
date, albeit minimal, provides hope for the emergence of new
concepts and a stronger evidence base to guide treatments.AUTHOR CONTRIBUTIONS
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